Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol as a potential treatment for psychosis
Cathy Davies, Sagnik Bhattacharyya
Therapeutic Advances in Psychopharmacology (2019) Vol. 9
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems
Julie Moltke, Chandni Hindocha
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 109
The Polypharmacological Effects of Cannabidiol
Jorge Iván Castillo-Arellano, Ana Canseco-Alba, Stephen J. Cutler, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3271-3271
Open Access | Times Cited: 70
Cannabinoids in the Pathophysiology of Skin Inflammation
Cristian Scheau, Ioana Anca Bădărău, Livia-Gratiela Mihai, et al.
Molecules (2020) Vol. 25, Iss. 3, pp. 652-652
Open Access | Times Cited: 83
The therapeutic potential of purified cannabidiol
Saoirse E. O′Sullivan, Sanne Jensen, Gitte Nykjaer Nikolajsen, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 29
Psychotic disorders as a framework for precision psychiatry
Fiona Coutts, Nikolaos Koutsouleris, Philip McGuire
Nature Reviews Neurology (2023)
Closed Access | Times Cited: 24
The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors
Kelly A. Sagar, Staci A. Gruber
CNS Drugs (2025)
Closed Access | Times Cited: 1
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies
Laura Fusar‐Poli, Vito Cavone, Silvia Tinacci, et al.
Brain Sciences (2020) Vol. 10, Iss. 9, pp. 572-572
Open Access | Times Cited: 66
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
Rafael G. dos Santos, Francisco Silveira Guimarães, José Alexandre S. Crippa, et al.
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 6, pp. 517-526
Closed Access | Times Cited: 59
Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank
Michael Wainberg, Grace Jacobs, Marta Di Forti, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 48
A scoping review of the use of cannabidiol in psychiatric disorders
Anna E. Kirkland, Matthew C. Fadus, Staci A. Gruber, et al.
Psychiatry Research (2021) Vol. 308, pp. 114347-114347
Open Access | Times Cited: 48
The Impact of THC and CBD in Schizophrenia: A Systematic Review
Saeed Ahmed, Robert M. Roth, Corneliu N. Stanciu, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 46
Exploring causal mechanisms of psychosis risk
Dominic Oliver, Edward Chesney, Alexis E. Cullen, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105699-105699
Open Access | Times Cited: 7
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
Marco Colizzi, Mirella Ruggeri, Sagnik Bhattacharyya
Frontiers in Psychology (2020) Vol. 11
Open Access | Times Cited: 49
Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review
Benedikt Fischer, Wayne Hall, Thiago Marques Fidalgo, et al.
Journal of Dual Diagnosis (2023) Vol. 19, Iss. 2-3, pp. 71-96
Open Access | Times Cited: 14
The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysis
Jack Wilson, Andrew Langcake, Zachary Bryant, et al.
Systematic Reviews (2025) Vol. 14, Iss. 1
Open Access
Future Perspectives of NMDAR in CNS Disorders
Toni Capó, Joan Biel Rebassa, Iu Raïch, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 877-877
Open Access
“Tobacco Is the Chief Medicinal Plant in My Work”: Therapeutic Uses of Tobacco in Peruvian Amazonian Medicine Exemplified by the Work of a Maestro Tabaquero
Ilana Berlowitz, Ernesto García Torres, Heinrich Walt, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 36
CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature
Serap Bilge, Barış Ekici
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 27
Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option?
W. Zieglgänsberger, Rudolf Brenneisen, Achim Berthele, et al.
Medical Cannabis and Cannabinoids (2022) Vol. 5, Iss. 1, pp. 61-75
Open Access | Times Cited: 20
Effects of cannabidiol on symptoms in people at clinical high risk for psychosis
Sagnik Bhattacharyya, Elizabeth Appiah‐Kusi, Robin Wilson, et al.
World Psychiatry (2024) Vol. 23, Iss. 3, pp. 451-452
Open Access | Times Cited: 4
A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis
Cathy Davies, Robin Wilson, Elizabeth Appiah‐Kusi, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 32
New insight in the cross-talk between microglia and schizophrenia: From the perspective of neurodevelopment
Jingjing Li, Yu Wang, Xiuxia Yuan, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
Indigenous-Amazonian Traditional Medicine’s Usage of the Tobacco Plant: A Transdisciplinary Ethnopsychological Mixed-Methods Case Study
Ilana Berlowitz, Ernesto García Torres, Caroline Maake, et al.
Plants (2023) Vol. 12, Iss. 2, pp. 346-346
Open Access | Times Cited: 9
The Development of Cannabinoids as Therapeutic Agents in the United States
Conor H. Murray, Brenda M. Gannon, Peter J. Winsauer, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 915-955
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top